Global Hyaluronic Acid (HA) Raw Material Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hyaluronic Acid (HA) Raw Material Market Research Report 2024
Hyaluronic acid also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated, forms in the plasma membrane instead of the Golgi apparatus, and can be very largehuman synovial HA averages about 7 million Da per molecule, or about 20000 disaccharide monomers, while other sources mention 3–4 million Da. As one of the chief components of the extracellular matrix, hyaluronan contributes significantly to cell proliferation and migration, and may also be involved in the progression of some malignant tumors.
According to Mr Accuracy reports’s new survey, global Hyaluronic Acid (HA) Raw Material market is projected to reach US$ 496.2 million in 2034, increasing from US$ 387.5 million in 2024, with the CAGR of 3.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hyaluronic Acid (HA) Raw Material market research.
Among the global companies that produce the hyaluronic acid raw material,the Bloomage Biotech became the TOP 1 player with 33% of the market share in 2019.
In terms of application, cosmetica is the largest segment with a market share of nearly 47% in 2019.Dietary Supplement and Medical accounted for about 38% and 4% of the global market.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hyaluronic Acid (HA) Raw Material market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Salix Pharmaceuticals
ALLERGAN
Lifecore Biomedical, LLC
Shiseido Co., Ltd.
Anika Therapeutics, Inc.
Smith & Nephew
Maruha Nichiro Corporation
Ferring B.V.
SEIKAGAKU CORPORATION
Genzyme Corporation
Roche
Contipro a.s.
Zimmer Biomet
Segment by Type
Animal Tissue Sourced
Synthetic
Others
Ophthalmology
Orthopedics
Dermatology
Drug Delivery
Medical Device Coating
Surgical Adhesion Prevention
Biomaterials and Implants
Cell and Tissue Preservation
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Hyaluronic Acid (HA) Raw Material report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Hyaluronic Acid (HA) Raw Material market is projected to reach US$ 496.2 million in 2034, increasing from US$ 387.5 million in 2024, with the CAGR of 3.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hyaluronic Acid (HA) Raw Material market research.
Among the global companies that produce the hyaluronic acid raw material,the Bloomage Biotech became the TOP 1 player with 33% of the market share in 2019.
In terms of application, cosmetica is the largest segment with a market share of nearly 47% in 2019.Dietary Supplement and Medical accounted for about 38% and 4% of the global market.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hyaluronic Acid (HA) Raw Material market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Salix Pharmaceuticals
ALLERGAN
Lifecore Biomedical, LLC
Shiseido Co., Ltd.
Anika Therapeutics, Inc.
Smith & Nephew
Maruha Nichiro Corporation
Ferring B.V.
SEIKAGAKU CORPORATION
Genzyme Corporation
Roche
Contipro a.s.
Zimmer Biomet
Segment by Type
Animal Tissue Sourced
Synthetic
Others
Segment by Application
Ophthalmology
Orthopedics
Dermatology
Drug Delivery
Medical Device Coating
Surgical Adhesion Prevention
Biomaterials and Implants
Cell and Tissue Preservation
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Hyaluronic Acid (HA) Raw Material report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices